47 /100
MEDIUM RISK
Score updated May 30, 2026

TENX — Tenax Therapeutics, Inc. Dilution Risk Tracker

Track TENX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TENX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
70
💰 Cash Runway
10
📊 Float Risk
55
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
46%
📜 Warrant Exercise 60%
• Massive warrant overhang: 120% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration 40%
• Score rose 23 points recently (worsening)
💰 Capital Raise 20%
• Active shelf registration ($300M, 95% of market cap)
🔔 Track TENX — Get forecast alerts →

💹 Market Data

Market Cap$314.85M
Shares Outstanding26.53M
Float10.61M
Cash$118.75M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 4.52M shares
#1 Ikarian Capital, LLC 967.6K shares
#2 Morgan Stanley 596.4K shares
#3 Perceptive Advisors Llc 439.1K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest775.9K
Days to Cover1.1
% of Float7.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
EFFECT EFFECT Apr 01, 2026
S-3 SHELF Mar 24, 2026
4 INSIDER TRANSACTION Feb 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track TENX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TENX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TENX
📊 TENX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TENX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.